Authors
Latest:
Leaders in academic ophthalmology discuss AI for eye screeningArtificial intelligence in a primary care and clinic settings increases the likelihood of catching diabetic retinopathy in underinsured patients, resulting in increased successful referrals.
Latest:
Pearls for managing diabetic retinopathy in pediatric patientsInsulin pumps, digital technology and outcome analyses are useful tools
Latest:
Serious adverse reaction halts gene therapy for diabetic macular edemaDespite setbacks in DME, Adverum Biotechnologies said it will continue to develop ADVM-022 for wet AMD.
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
OPT-302 VEGF-C/D “trap” molecule for AMD promising in Phase 2b, moves to Phase 3OPT-302 in combination with standard-of-care anti-VEGF-A agents shown to improve visual acuity, anatomic endpoints.
Latest:
Take-Home Points for the Treatment of AMD and DMEDavid A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
Latest:
How ophthalmology is pioneering the field of artificial intelligenceRetinal imaging tests are providing material to train and test decision support systems.
Latest:
Pediatric ophthalmologists target inherited retinal diseasesNew opportunities continue to develop in an evolving landscape.
Latest:
VEGF and beyond: therapeutic targeting in retinal vascular disordersPromoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.
Latest:
Optimizing Care For Patients With Retinal DisordersKey takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Dexamethasone rebuttal: Who should perform intravitreal injections?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Significance of periphery in diabetic retinopathy diagnosis and managementBeing able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.
Latest:
2023: What awaits ophthalmology in the year aheadAs we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
Latest:
Big data: Driving opportunity for real-world evidenceEvidence-based medicine can lead to personalized care, better results for patients
Latest:
Practice perspective: Academic retinaA window into the world of academic retina practice today.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Discussing worldwide pathological myopiaDr. Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
Expanding our vision of steroid-eluting implantsHow long-term intravitreal steroid technology fits into a modern clinic.
Latest:
Adapting medical retina service in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key
Latest:
Perspectives on intravenous bevacizumab repackaged for intravitreal useAlthough off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.
Latest:
Dexamethasone rebuttal: Who should perform intravitreal injections?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
Monitoring patients for neovascular AMD in the office and at homeTechnology that allows consistent monitoring could be useful tools in 2022—and may be the key to tracking nAMD progression in fellow eyes among patients who have had intervals extended due to new technology.
Latest:
Impressions and take away points from Patient Case #2A retina specialist discusses impressions and key take away points from patient case.
